1563PDMagnitude of clinical benefit in trials supporting US Food and Drug Administration (FDA) accelerated approval (AA) and European Medicines Agency (EMA) conditional marketing authorisation (CMA) and subsequent trials supporting conversion to full approval

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 29; no. suppl_8
Main Authors Borrell Puy, M, Molto Valiente, C, Vokinger, K, Hwang, T, Ocana Fernandez, A, Templeton, A J, Seruga, B, Gich Saladich, I, Barnadas, A, Amir, E, Tibau, A
Format Journal Article
LanguageEnglish
Published Oxford University Press 01.10.2018
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy297.007